Phenytoin and carbamazepine in trigeminal neuralgia: marketing-based versus evidence-based treatment
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Pain Research"
DOI: 10.2147/jpr.s141896
Abstract: Most review articles support carbamazepine as a first-line pharmacotherapy for idiopathic trigeminal neuralgia.1–3 However, the empirical support for this recommendation is somewhat suspect. Phenytoin, as the prototype for all anticonvulsants, was already positioned as an… read more here.
Keywords: treatment; phenytoin carbamazepine; neuralgia; trigeminal neuralgia ... See more keywords